相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials
Xiaoying Qian et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment
Marija Balic et al.
BREAST CARE (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer
Stephanie Strobl et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Extended duration of adjuvant aromatase inhibitor in breast cancer: a meta-analysis of randomized controlled trials
Zackariah Clement et al.
GLAND SURGERY (2018)
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline
Sukhbinder Dhesy-Thind et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
Peyman Hadji et al.
JOURNAL OF BONE ONCOLOGY (2017)
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
P. Hadji et al.
ANNALS OF ONCOLOGY (2016)
Bone health in the elderly cancer patient: A SIOG position paper
J. J. Body et al.
CANCER TREATMENT REVIEWS (2016)
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
E. Senkus et al.
ANNALS OF ONCOLOGY (2015)
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Michael Gnant et al.
LANCET (2015)
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
R. Coleman et al.
LANCET (2015)
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
M. Gnant et al.
ANNALS OF ONCOLOGY (2015)
'The dilemmas of breast cancer treatment and increased fracture risk' by Malik
B. Bouvard et al.
ANNALS OF ONCOLOGY (2014)
Fracture incidence after 3 years of aromatase inhibitor therapy
B. Bouvard et al.
ANNALS OF ONCOLOGY (2014)
Bone health in cancer patients: ESMO Clinical Practice Guidelines
R. Coleman et al.
ANNALS OF ONCOLOGY (2014)
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
Robert Coleman et al.
LANCET ONCOLOGY (2014)
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
R. Coleman et al.
ANNALS OF ONCOLOGY (2013)
Cancer Therapy Associated Bone Loss: Implications for Hip Fractures in Mid-Life Women with Breast Cancer
Beatrice J. Edwards et al.
CLINICAL CANCER RESEARCH (2011)
Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis
Eitan Amir et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
M. Rabaglio et al.
ANNALS OF ONCOLOGY (2009)
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC
Stephanie L. Hines et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
Peyman Hadji
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2009)
Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women
Dana Bliuc et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group
David M. Reid et al.
CANCER TREATMENT REVIEWS (2008)
Letrozole in the extended adjuvant setting: MA.17
Paul E. Goss
BREAST CANCER RESEARCH AND TREATMENT (2007)
Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women
Paul E. Goss et al.
BREAST CANCER RESEARCH (2007)
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer
Janice M. Walshe et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Changes on bone mineral density after adjuvant treatment in women with non-metastatic breast cancer
LM Rodríguez-Rodríguez et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer
NC Greep et al.
AMERICAN JOURNAL OF MEDICINE (2003)
分享论文
